Alterity Therapeutics Ltd. ADR (ATHE) News, Price and Chart - FAWS

Your browser has either disabled or does not support javascript. Javascript is required for full website experience.

Fri February 26th, 2021

- 03:42
  EarningsAnalysisAlterity Therapeutics Ltd (ATHE) CEO David Stamler on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha

Tue September 1st, 2020

- 00:45
  RumorsAlterity Therapeutics Ltd. Sponsored ADR (ATHE), Alterity Therapeutics Ltd - ADR (ATHE) on watch amid unconfirmed chatterTwitter

SPY$395.63-4.9%

QQQ$315.85-7.5%

DOW$64.14-0.67%

AAPL$121.1-10%

PINS$69.6-18%

RUN$5721%

SPLK$134.8-9.2%

SPY$395.63-4.9%

QQQ$315.85-7.5%

DOW$64.14-0.67%

AAPL$121.1-10%

PINS$69.6-18%

RUN$5721%

SPLK$134.8-9.2%

About Developer Contact